CDP-CholinevsLion's Mane

CDP-Choline is hydrolyzed by nucleotidases and phosphatases into choline and cytidine after oral ingestion. Choline enters the acetylcholine synthesis pathway via choline acetyltransferase. Cytidine is phosphorylated to CTP and converted to uridine monophosphate (UMP), which enters the Kennedy pathway and stimulates the synthesis of phosphatidylcholine via the enzyme CTP:phosphocholine cytidylyltransferase — phosphatidylcholine is a critical component of neuronal cell membranes and synaptic vesicles. This dual mechanism simultaneously boosts neurotransmitter production and repairs membrane damage from oxidative stress or ischemia. CDP-Choline also increases dopamine D2 receptor density in the striatum and enhances dopamine release. It may modulate glutamate excitotoxicity and support mitochondrial function.

Lion's Mane contains two classes of bioactive compounds: hericenones (A-H, found in the fruiting body) and erinacines (A-I, found in the mycelium). Both stimulate the synthesis of nerve growth factor (NGF) in astrocytes and neurons — hericenones may act through enhancement of NGF gene expression, while erinacines cross the blood-brain barrier and directly induce NGF. NGF binds to TrkA receptors and is essential for the survival, maintenance, and regeneration of cholinergic neurons, particularly in the hippocampus and basal forebrain. This promotes neurogenesis, dendritic arborization, and remyelination of nerve fibers. Lion's Mane also reduces neuroinflammation through inhibition of NF-κB signaling and suppression of pro-inflammatory cytokine production. It may enhance BDNF expression and support the gut-brain axis.